|
ABX advanced biochemical compounds |
|
|
|
|
| 1997: |
Foundation of ABX GmbH Vision: Production of PET Precursor |
| 1998: |
Start with own laboratory ( 30 sqm ) Start with CRO business |
| 2001: | Start of kit production in new facilities in Robert-Bosch-Strasse |
| 2002: |
Split off of CRO business into independent ABX-CRO GmbH Purchase of facilities in Heinrich-Glaeser-Strasse 10 - 14 and start of reconstruction |
| 2003: |
Chemical laboratories in Heinrich-Glaeser-Strasse 12 operational Emergency stock for mannose triflate and FDG kits in the US |
| 2004: |
New 2,100 sqm administration, laboratory, clean room A, B, C, D facilities, assembling and stock area Successful audit for GMP production by Regierungspräsidium Dresden ( mannose triflate, cryptand, FDG kits, FLT kits ) |
| 2005: |
Successful audit by FDA for GMP compliance for active pharmaceutical ingredients Successful audit by "Regierungspräsidium Dresden" for license of wholesalers |
| 2006: |
Change in ownership - new owner: CIL ( Cambridge Isotope Laboratories, Inc. )
|
| 2007: |
Hot ( radiosynthesis ) laboratory operational
|